AlphaYou
Overview
Smart money at a glance
Filings to Sep 27, 2026Net selling: insiders sold $8.3M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$8.3M netNet selling
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 1 added, 4 cutMore cutting
- Federal contractsUSAspending.gov, last 12 months
- 10+ awardsAwards on record
Key stats
Fundamentals Sep 27- Open
- $236.37
- 52-wk high
- $248.84
- High
- $238.25
- 52-wk low
- $168.97
- Low
- $235.48
- Prev close
- $236.59
- Mkt cap
- $26.08B
- P/E
- 25.1x
- Volume
- 739.4K
- Fwd P/E
- 19.5x
- Beta
- 0.55
- Div yield
- 1.40%
- P/S
- 2.3x
- P/B
- 3.4x
- Profit margin
- +9.2%
- Op margin
- +15.2%
- ROE
- +14.6%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about DGX filings
Are insiders buying or selling Quest Diagnostics Incorporated (DGX) stock?
Net selling: insiders sold $8.3M and bought $0 of DGX stock on the open market in the 90 days to Sep 27, 2026, according to SEC Form 4 filings. $8.3M of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was Prevoznik, Michael E (SVP & General Counsel), who sold $5.5M. The latest filing was on Sep 3, 2026.
Which members of Congress have traded DGX recently?
None. No member of Congress disclosed a DGX trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this DGX smart-money data?
This summary uses filings available on Sep 27, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (1)
- BA
Balyasny
$57.8M
added
Sells/Trims (2)
- QR
Qube Research
$71.2M
trimmed
- SQ
Squarepoint
$42.8M
trimmed
What insiders are doing
What Congress is doing
Buys (1)
Sells (2)
How top traders are positioned
No tracked top-trader positions in DGX right now.
Live Hyperliquid positioning - not every stock is covered
Activist stakes, short interest & more
Earnings
Earnings came in 11.0% above what analysts expected.
Earnings per share
$2.81 expected
Revenue
No comparable estimate
FY2026 guidance
$11.95B to $12.05B
No comparable estimate
Reports Oct 20, 2026, in 23 days
Estimates as of Sep 27, 2026
EPS expected
$2.82 to $2.91
Revenue expected
11 analysts
Last 30 days
Analysts raising estimates
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $2.82B | $2.81B | $2.90B | $3.04B |
| Cost of what it sold | $1.87B | $1.89B | $1.95B | $2.02B |
| Gross profit | $949.0M | $914.0M | $942.0M | $1.03B |
| What it spent | ||||
| Sales and admin | $501.0M | $486.0M | $504.0M | $529.0M |
| Other operating costs | $62.0M | $37.0M | $39.0M | $39.0M |
| Total operating expenses | $563.0M | $523.0M | $543.0M | $568.0M |
| What was left | ||||
| Operating profit | $386.0M | $391.0M | $399.0M | $459.0M |
| Interest on debt | $69.0M | $67.0M | $63.0M | $63.0M |
| Profit before tax | $336.0M | $337.0M | $334.0M | $412.0M |
| Tax | $77.0M | $81.0M | $74.0M | $88.0M |
| Net profit | $245.0M | $245.0M | $252.0M | $320.0M |
| EBITDA | $547.0M | $546.0M | $434.0M | $481.0M |
Technicals
Price structure
This stock is trending upward.
Trend
Constructive
60 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage leans bullish
Tone of tracked coverage
Wisconsin Joins $2.3M Labcorp Data Breach Settlement
NeutralSep 25Quest Diagnostics stock gains 1.48 percent after Truist raises target
BullishSep 25Quest Diagnostics Stock Gains 36.3% YTD: What's Behind the Rally?
BullishSep 25Quest Diagnostics stock heads into the open after a 0.4 percent gain
Leans bullishSep 25Quest Diagnostics stock reports growth as reimbursement risk rises
NeutralSep 24Inspire Medical Systems, Inc. (INSP) latest stock news and headlines
NeutralSep 24Investigation launched into STAAR Surgical for possible fiduciary breaches affecting shareholders.
Leans bearishSep 23FDA panel endorses first-of-a-kind cancer blood test from Grail
NeutralSep 23
Macro
21 macro signals shaping DGX right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results